Galera Therapeutics Financials

Galera Therapeutics Stock Summary

Galera Therapeutics competes with Mereo BioPharma, Terns Pharmaceuticals, PDS Biotechnology, Inozyme Pharma, and Hookipa Pharma. Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. Galera Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 30 people.

Galera Therapeutics Key Financial Ratios

Galera Therapeutics' financial ratios allow both analysts and investors to convert raw data from Galera Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Galera Therapeutics over time and compare it to other companies across industries.

Galera Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Galera Therapeutics's current stock value. Our valuation model uses many indicators to compare Galera Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Galera Therapeutics competition to find correlations between indicators driving Galera Therapeutics's intrinsic value. More Info.Galera Therapeutics is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Galera Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Galera Therapeutics' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Galera Therapeutics Market Pulse

Along with financial statement analysis, the daily predictive indicators of Galera Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Galera Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Galera Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Galera Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Galera Therapeutics's daily price indicators and compare them against related drivers.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

If you are still planning to invest in Galera Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Galera Therapeutics' history and understand the potential risks before investing.